| Registrars: | Equiniti |
| CEO: | William D Brown |
| CFO: | Lachlan Smith |
| Independent Non-Executive Director: | John Louis Ely |
| Independent Non-Executive Director: | Ian Ardill |
| Non-Executive Chairman: | Geoffrey Alan Berg |
| Non-Executive Dir: | John McKenna |
| Address: | 2 Drummond Crescent, Riverside Business Park, Irvine, Ayrshire, United Kingdom, KA11 5AN |
| Phone: | +44(0) 1294 317073 |
| Website: | http://rualifesciences.com/ |
| Sector: | Health Care(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0033360586 |
| Currency | UK Pounds |
| Share Price | 30.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 30.50 |
| 52 Week Low | 11.00 |
| Volume | 150,506 |
| Shares Issued | 62.06m |
| Market Cap | £18.62m |
| RiskGrade | 290 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:06 | 18,500 @ 29.40p |
| 13:47 | 5 @ 30.00p |
| 10:27 | 27,932 @ 29.35p |
| 11:13 | 5,000 @ 29.40p |
| 11:08 | 20,000 @ 29.28p |
| CEO | William D Brown |
| CFO | Lachlan Smith |
You are here: research